§ 13F · FUND PROFILE
Vestal Point Capital, LP.
AUM · $4.3B (13F)Positions · 68Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$328M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | BMRN | BioMarin Pharmaceutical Inc | 6.03M | $345M | 8.1% | +69% |
| 2 | NBIX | Neurocrine Biosciences Inc | 1.88M | $317M | 7.4% | +50% |
| 3 | ABVX | Abivax SA | 2.35M | $313M | 7.3% | +57% |
| 4 | UTHR | United Therapeutics Corp | 435K | $236M | 5.5% | +480% |
| 5 | ELVN | Enliven Therapeutics Inc | 4.00M | $203M | 4.7% | +23% |
| 6 | NRIX | Nurix Therapeutics Inc | 8.05M | $195M | 4.6% | +24% |
| 7 | BCAX | Bicara Therapeutics Inc | 5.25M | $156M | 3.6% | −3% |
| 8 | TSHA | Taysha Gene Therapies Inc | 19.41M | $132M | 3.1% | +8% |
| 9 | ARWR | Arrowhead Pharmaceuticals Inc | 1.57M | $128M | 3.0% | −31% |
| 10 | ABT | Abbott Laboratories | 1.40M | $127M | 3.0% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VESTAL SIGNAL
AC read
Vestal Point Capital, LP is a Other fund managing $4.3 billion in assets. The fund runs a portfolio of 68 positions.
Read the full dossier →